Shandong Zhushi Pharmaceutical Group won the "First Prize of Shandong Enterprise Technology Innovation Award"

Recently, the excellent innovation project proposed by Shandong Zhushi Pharmaceutical Group Co., Ltd.: the research, development and application of anti-novel coronavirus functional cyclodextrin based on the three-dimensional quantitative purchase effect relationship was selected and approved by the Shandong Enterprise Technology Innovation Promotion Association, and won the "First Prize of Shandong Enterprise Technology Innovation Outstanding Achievement" certificate! 

Cyclodextrin is a molecular material with wide application value and has great potential for anti-novel coronavirus. Based on the in-depth study of the three-dimensional quantitative purchase and effect relationship, this project uses this relationship to assist in the design of the development and application of functional cyclodextrin. The nomination of this outstanding project once again proves the strength and leading position of Zhu's Pharmaceutical Group in scientific and technological innovation.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW